← back to search

John F. Peden

Illumina (United Kingdom) · GB
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Genetic Associations and Epidemiology, Genomics and Phylogenetic Studies, RNA modifications and cancer, and Cancer Genomics and Diagnostics.
h-index
53
citations
55,809
works
117
NIH funding
primary concept
email

Recent publications

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
Nature Communications 2016cited by 1,791position: middledoi
Modulation of Genetic Associations with Serum Urate Levels by Body-Mass-Index in Humans
PLoS ONE 2015cited by 1,234position: middledoi
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
Annals of Oncology 2015cited by 52position: middledoi
Abstract B017: A targeted sequencing approach to characterize the mutational profiles of 178 genes in 2600 primary breast tumors
Molecular Cancer Research 2013cited by 0position: middledoi
Large-scale association analysis identifies new risk loci for coronary artery disease
Nature Genetics 2012cited by 1,666position: middledoi
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Nature Genetics 2012cited by 874position: middledoi
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
Nature Genetics 2012cited by 857position: middledoi
Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
Journal of the American College of Cardiology 2012cited by 184position: middledoi
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
Blood 2012cited by 139position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Oscar M. Rueda · University of Cambridge1 papers (2013–2013)Bernard Pereira · Novartis (United States)1 papers (2013–2013) · 1 papers (2015–2015) · 1 papers (2015–2015)Jean Abraham · University of Cambridge1 papers (2013–2013)Stephen C. Benz · Klinikum Sindelfingen-Böblingen1 papers (2015–2015)David L. Bentley · University of Arizona1 papers (2013–2013)Charles Swanton · Cancer Evolution and Genome Instability Laboratory1 papers (2015–2015)Suet‐Feung Chin · Cancer Research UK Cambridge Center1 papers (2013–2013)Zoltán Szállási · Semmelweis University1 papers (2015–2015)Tim Forshew · Neogen Europe (United Kingdom)1 papers (2015–2015)Sean Humphray · University of Minnesota, Twin Cities1 papers (2015–2015)Gordon Stamp · The Ohio State University Wexner Medical Center1 papers (2015–2015) · 1 papers (2015–2015)Zoya Kingsbury · University of Minnesota, Twin Cities1 papers (2015–2015) · 1 papers (2015–2015)Pierre‐Yves Dietrich · University of Geneva1 papers (2015–2015) · 1 papers (2015–2015)Andrew Rowan · The Francis Crick Institute1 papers (2015–2015)Nicholas McGranahan · London Cancer1 papers (2015–2015)